In summary, these findings suggest that the biomarkers FINC, PMGE, and TPM1 hold prognostic potential in stroke patients, particularly for differentiating between cardioembolic and atherothrombotic origins and predicting patient outcomes. This evidence concerns the gene TPM1 and stroke disorder.